Atıf İçin Kopyala
İNCE E., ERTEM M., İLERİ D. T., DALVA K., TOPÇUOĞLU P., Uysal Z.
TURKISH JOURNAL OF HEMATOLOGY, cilt.27, sa.1, ss.8-14, 2010 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
27
Sayı:
1
-
Basım Tarihi:
2010
-
Dergi Adı:
TURKISH JOURNAL OF HEMATOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.8-14
-
Anahtar Kelimeler:
Thalassemia major, mixed chimerism, pediatrics, chimerism, hematopoietic stem cell transplantation, non-malignant, BONE-MARROW-TRANSPLANTATION, BETA-THALASSEMIA, CHILDREN, GRAFT, RELAPSE, BLOOD
-
Ankara Üniversitesi Adresli:
Evet
Özet
Objective: Stable mixed chimerism (MC) may result in cure for thalassemia major patients following hematopoetic stem cell transplantation (HSCT), but rejection can occur. Twenty-eight HSCTs for thalassemia major were reviewed retrospectively to evaluate the clinical course of MC with possible risk factors and predictors of outcome, with a median follow-up of 1669 days (811-3576 days).